Atsushi Kato

Activities

Activities per year 2002 2015 2019

• 16 Oral presentation
• 10 social activities
• 2 Other educational activity

Activities per year

Search results

• Discovery of potent glycosidase inhibitors by in situ analysis of a library of hybrid molecules generated via click chemistry.

  Kato, A. (Speaker)

  2018/07/15 → 2018/07/19

  Activity: Talk or presentation › Oral presentation

• In silico study on the interaction of high affinity ligand calystegine B2 with β-glucocerebrosidase

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• Protective effects of dietary 1,5-Anhydro-D-glucitol in diabetes and metabolic syndrome

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• Catalytic asymmetric syntheses and biological evaluations of α-1-C-substituted L-iminofuranose derivatives as α-glucosidase inhibitor

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• Synthesis and interactions of rhamnose iminosugar mimics with the rhamnose operon, rhamnosidases, and rhamnose isomerase

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• Rare sugars as potential inducers of the rhamnose operon: Biotechnology and chemistry in the production of 6-deoxy-hexoses and related monosaccharides

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• Fluoro azetidines and difluoro prolines from D-glucose; Inhibition of pancreatic cancer cell growth by a fluoro azetidine

  Kato, A. (Speaker)

  2014/08/10 → 2014/08/14

  Activity: Talk or presentation › Oral presentation

• A nitro sugar based route to branched-chain polyhydroxylated octahydro-1H-indole-4,5,6-triols, as new potential glycosides inhibitors.

  Kato, A. (Speaker)

  2014/05/28 → 2014/05/30

  Activity: Talk or presentation › Oral presentation

• In vitro Iinvestigation of a novel iminosugar, TOP-DNJ.

  Kato, A. (Speaker)

  2013/10/21 → 2013/10/23

  Activity: Talk or presentation › Oral presentation

• Synthesis and biological evaluation of azetidines derivatives from carbohydrates.

  Kato, A. (Speaker)

  2012/07/22 → 2012/07/27

  Activity: Talk or presentation › Oral presentation

• Synthesis of glycosidase inhibitors based on bicyclic azetidines for the treatment of cancer.

  Kato, A. (Speaker)

  2012/07/22 → 2012/07/27

  Activity: Talk or presentation › Oral presentation

• Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors

  Kato, A. (Speaker)

  2011/11/29 → 2011/12/02

  Activity: Talk or presentation › Oral presentation

• Biologically active novel branched pyrrolidines: synthesis of isoDAB and isoLAB.

  Kato, A. (Speaker)

  2010/12/15 → 2010/12/20

  Activity: Talk or presentation › Oral presentation

• Synthesis of potent glycosidase inhibitors including DGJNAc: The first iminosugar to show specific nanomolar inhibiton of α-N-acetylgalactosaminidases.

  Kato, A. (Speaker)

  2010/12/15 → 2010/12/20

  Activity: Talk or presentation › Oral presentation

• Manipulating the glucuronolactone scaffold: Efficient synthesis of potent and specific glycosidase Inhibitors.

  Kato, A. (Speaker)

  2010/08/01 → 2010/08/06

  Activity: Talk or presentation › Oral presentation

• A strategy for the synthesis of all 16 stereoisomers of homonojirimycin (HNJ).

  Kato, A. (Speaker)

  2010/08/01 → 2010/08/06

  Activity: Talk or presentation › Oral presentation